Search Results 271-280 of 19750 for CLL
-
... Chronic Lymphocytic Leukemia Rochester, MN. The purpose of this study is to ... CLL as well as non-CLL patients. Study to Validate Methods Assessment of ...
-
For patients with CLL. Confirmed diagnosis of chronic lymphocytic leukemia (CLL). For patients with NHL. Histologically confirmed diagnosis of B- or T-cell ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...
-
... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy control (HC) donors. Database of All Patients with Peritoneal Surface Malignancies ...
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...
-
... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...